Lexaria Bioscience
Quarterly Financials
| Values in thousands | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 |
|---|---|---|---|---|
Revenue | $84 | $145 | $151 | $-3 |
Gross Profit | 84 | 129 | 146 | -6 |
EBITDA | -1,727 | -636 | -1,110 | -999 |
EBIT | -1,742 | -652 | -1,150 | -1,070 |
Net Income | -1,781 | -649 | -1,179 | -1,239 |
Net Change In Cash | 84 | 145 | 151 | -3 |
Free Cash Flow | -1,288 | -676 | -1,221 | -1,690 |
Cash | 8,459 | 4,705 | 1,954 | 1,352 |
Basic Shares | 13,855 | 10,765 | 9,051 | 6,614 |
Annual Financials
| Values in thousands | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
|---|---|---|---|---|
Revenue | $226 | $255 | $722 | $384 |
Gross Profit | 194 | 183 | 547 | 285 |
EBITDA | -6,388 | -6,516 | -5,575 | -4,002 |
EBIT | -6,534 | -6,663 | -5,722 | -4,148 |
Net Income | -6,664 | -7,269 | -2,504 | -4,030 |
Net Change In Cash | 226 | 255 | 722 | 384 |
Free Cash Flow | -6,050 | -5,010 | -4,069 | -2,696 |
Cash | 1,352 | 5,813 | 10,917 | 1,293 |
Basic Shares | 6,614 | 5,885 | 4,391 | 2,773 |
